Physician profile
Clark E Conant, III
NPI 1588626246
$4,157.03
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $1,607 · 2021: $732 · 2022: $16.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $710.23 | 2019-2021 | |
| Amgen INC. | $547.90 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $404.24 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $382.32 | 2019-2021 | |
| Pfizer INC. | $298.12 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $203.34 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $196.43 | 2019-2021 | |
| Amarin Pharma, INC. | $184.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $148.57 | 2019-2021 | |
| Allergan, INC. | $133.56 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $128.82 | 2019-2021 | |
| Astellas Pharma US INC | $102.65 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $99.22 | 2019-2021 | |
| Lilly USA, LLC | $72.17 | 2019-2021 | |
| Almatica Pharma LLC | $57.66 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.41 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $50.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.95 | 2019-2022 | |
| Abbott Laboratories | $45.10 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $43.23 | 2019 | |
| Eisai INC. | $33.13 | 2020-2021 | |
| Horizon Therapeutics Plc | $31.43 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $22.67 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.59 | 2019-2021 | |
| Abbvie INC. | $16.11 | 2019 | |
| Acclarent, INC | $15.57 | 2019 | |
| Circassia INC. | $14.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.23 | 2019 | |
| Daiichi Sankyo INC. | $13.74 | 2019 | |
| Ibsa Pharma INC. | $13.41 | 2021 | |
| Intercept Pharmaceuticals, INC. | $13.17 | 2019 | |
| Redhill Biopharma INC. | $12.89 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Conant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.